{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:05:44Z","timestamp":1784250344599,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Research Project of Traditional Chinese Medicine in Henan Province","award":["No.024ZY3032"],"award-info":[{"award-number":["No.024ZY3032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49687-6","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:25:39Z","timestamp":1779128739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-derived type IX collagen regulates dormancy in triple-negative breast cancer cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"3","key":"49687_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"Cancer J. Clin."},{"issue":"9","key":"49687_CR2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.22618","volume":"109","author":"KR Bauer","year":"2007","unstructured":"Bauer, K. R. et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)\u2010negative, and HER2\u2010negative invasive breast cancer, the so\u2010called triple\u2010negative phenotype. Cancer 109 (9), 1721\u20131728 (2007).","journal-title":"Cancer"},{"issue":"22","key":"49687_CR3","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1002\/cncr.27581","volume":"118","author":"NU Lin","year":"2012","unstructured":"Lin, N. U. et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer 118 (22), 5463\u20135472 (2012).","journal-title":"Cancer"},{"issue":"3","key":"49687_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2202809","volume":"387","author":"J Cortes","year":"2022","unstructured":"Cortes, J. et al. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer. N. Engl. J. Med. 387 (3), 217\u2013226 (2022).","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"49687_CR5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","volume":"384","author":"A Bardia","year":"2021","unstructured":"Bardia, A. et al. Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer. N. Engl. J. Med. 384 (16), 1529\u20131541 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"4888","key":"49687_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/bmj.2.4888.607","volume":"2","author":"G Hadfield","year":"1954","unstructured":"Hadfield, G. The Dormant Cancer Cell. Bmj-British Med. J. 2 (4888), 607\u2013610 (1954).","journal-title":"Bmj-British Med. J."},{"key":"49687_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.acr.2016.07.002","volume":"132","author":"N Linde","year":"2016","unstructured":"Linde, N., Fluegen, G. & Aguirre-Ghiso, J. A. The relationship between dormant cancer cells and their microenvironment. Adv. Cancer Res. 132, 45\u201371 (2016).","journal-title":"Adv. Cancer Res."},{"issue":"6409","key":"49687_CR8","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues, J. et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361 (6409), 1353\u2013 (2018).","journal-title":"Science"},{"issue":"1","key":"49687_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s43018-021-00291-9","volume":"3","author":"JS Di Martino","year":"2021","unstructured":"Di Martino, J. S. et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat. Cancer. 3 (1), 90\u2013107 (2021).","journal-title":"Nat. Cancer"},{"issue":"1","key":"49687_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00018-024-05466-y","volume":"81","author":"TC Zhang","year":"2024","unstructured":"Zhang, T. C. et al. Stromal softness confines pancreatic cancer growth through lysosomal-cathepsin mediated YAP1 degradation. Cell. Mol. Life Sci. 81 (1), 442 (2024).","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"49687_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/2159-8290.CD-16-0822","volume":"7","author":"ET Goddard","year":"2017","unstructured":"Goddard, E. T. et al. The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. Cancer Discov. 7 (2), 177\u2013187 (2017).","journal-title":"Cancer Discov."},{"issue":"41","key":"49687_CR12","doi-asserted-by":"publisher","first-page":"e2204758119","DOI":"10.1073\/pnas.2204758119","volume":"119","author":"R Roy","year":"2022","unstructured":"Roy, R. et al. Escape from breast tumor dormancy: The convergence of obesity and menopause. Proc. Natl. Acad. Sci. U S A. 119 (41), e2204758119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"49687_CR13","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.celrep.2017.04.005","volume":"19","author":"C Rachman-Tzemah","year":"2017","unstructured":"Rachman-Tzemah, C. et al. Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases. Cell. Rep. 19 (4), 774\u2013784 (2017).","journal-title":"Cell. Rep."},{"issue":"7","key":"49687_CR14","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1182\/blood-2004-01-0064","volume":"104","author":"A Saudemont","year":"2004","unstructured":"Saudemont, A. & Quesnel, B. In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 104 (7), 2124\u20132133 (2004).","journal-title":"Blood"},{"issue":"10","key":"49687_CR15","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","volume":"185","author":"P Baldominos","year":"2022","unstructured":"Baldominos, P. et al. Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell 185 (10), 1694\u20131708e19 (2022).","journal-title":"Cell"},{"issue":"7958","key":"49687_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41586-023-05880-5","volume":"616","author":"J Hu","year":"2023","unstructured":"Hu, J. et al. STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma. Nature 616 (7958), 806\u2013 (2023).","journal-title":"Nature"},{"issue":"3","key":"49687_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/B:BREA.0000004377.12288.3c","volume":"82","author":"GN Naumov","year":"2003","unstructured":"Naumov, G. N. et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res. Treat. 82 (3), 199\u2013206 (2003).","journal-title":"Breast Cancer Res. Treat."},{"key":"49687_CR18","doi-asserted-by":"publisher","first-page":"216011","DOI":"10.1016\/j.canlet.2022.216011","volume":"554","author":"J Feng","year":"2023","unstructured":"Feng, J. et al. Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy. Cancer Lett. 554, 216011 (2023).","journal-title":"Cancer Lett."},{"issue":"6","key":"49687_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4161\/auto.28577","volume":"10","author":"Z Lu","year":"2014","unstructured":"Lu, Z. et al. DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells. Autophagy 10 (6), 1071\u20131092 (2014).","journal-title":"Autophagy"},{"issue":"10024","key":"49687_CR20","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(15)01037-5","volume":"387","author":"ND James","year":"2016","unstructured":"James, N. D. et al. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet 387 (10024), 1163\u20131177 (2016).","journal-title":"Lancet"},{"issue":"5","key":"49687_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/15384101.2016.1220461","volume":"16","author":"S Yano","year":"2017","unstructured":"Yano, S. et al. Cell-cycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging. Cell. Cycle. 16 (5), 406\u2013414 (2017).","journal-title":"Cell. Cycle"},{"issue":"9","key":"49687_CR22","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1172\/JCI96393","volume":"128","author":"I Puig","year":"2018","unstructured":"Puig, I. et al. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence. J. Clin. Invest. 128 (9), 3887\u20133905 (2018).","journal-title":"J. Clin. Invest."},{"issue":"11","key":"49687_CR23","doi-asserted-by":"publisher","first-page":"eaaz4157","DOI":"10.1126\/sciadv.aaz4157","volume":"6","author":"LE Barney","year":"2020","unstructured":"Barney, L. E. et al. Tumor cell-organized fibronectin maintenance of a dormant breast cancer population. Sci. Adv. 6 (11), eaaz4157 (2020).","journal-title":"Sci. Adv."},{"issue":"1","key":"49687_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-024-03449-4","volume":"24","author":"S P\u00e9rez-D\u00edaz","year":"2024","unstructured":"P\u00e9rez-D\u00edaz, S. et al. The potential role of collagen type VII in breast cancer proliferation. Cancer Cell. Int. 24 (1), 254 (2024).","journal-title":"Cancer Cell. Int."},{"issue":"2","key":"49687_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbrc.2017.04.055","volume":"487","author":"Y Hong","year":"2017","unstructured":"Hong, Y. et al. Patient sample-oriented analysis of gene expression highlights extracellular signatures in breast cancer progression. Biochem. Biophys. Res. Commun. 487 (2), 307\u2013312 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7924","key":"49687_CR26","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-022-05043-y","volume":"608","author":"Y Ohta","year":"2022","unstructured":"Ohta, Y. et al. Cell\u2013matrix interface regulates dormancy in human colon cancer stem cells. Nature 608 (7924), 784\u2013794 (2022).","journal-title":"Nature"},{"issue":"14","key":"49687_CR27","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1158\/0008-5472.CAN-09-2356","volume":"70","author":"D Barkan","year":"2010","unstructured":"Barkan, D. et al. Metastatic Growth from Dormant Cells Induced by a Col-I\u2013Enriched Fibrotic Environment. Cancer Res. 70 (14), 5706\u20135716 (2010).","journal-title":"Cancer Res."},{"issue":"6","key":"49687_CR28","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52 (6), 1399\u20131405 (1992).","journal-title":"Cancer Res."},{"issue":"1","key":"49687_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13046-023-02663-8","volume":"42","author":"JL Hancock","year":"2023","unstructured":"Hancock, J. L. et al. COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. J. Exp. Clin. Cancer Res. 42 (1), 90 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7864","key":"49687_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-021-03614-z","volume":"594","author":"AL Correia","year":"2021","unstructured":"Correia, A. L. et al. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy. Nature 594 (7864), 566\u2013571 (2021).","journal-title":"Nature"},{"key":"49687_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2019.02.032","volume":"450","author":"RT Bishop","year":"2019","unstructured":"Bishop, R. T. et al. Pharmacological inhibition of the IKK\u03b5\/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer. Cancer Lett. 450, 76\u201387 (2019).","journal-title":"Cancer Lett."},{"issue":"D1","key":"49687_CR32","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2024","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2024).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"49687_CR33","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"49687_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"49687_CR35","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1084\/jem.20120565","volume":"209","author":"H Jung","year":"2012","unstructured":"Jung, H. et al. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. J. Exp. Med. 209 (13), 2409\u20132422 (2012).","journal-title":"J. Exp. Med."},{"issue":"8020","key":"49687_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-024-07554-2","volume":"631","author":"Y Konagaya","year":"2024","unstructured":"Konagaya, Y. et al. An intermediate Rb-E2F activity state safeguards proliferation commitment. Nature 631 (8020), 424\u2013431 (2024).","journal-title":"Nature"},{"issue":"2","key":"49687_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/ncb3465","volume":"19","author":"G Fluegen","year":"2017","unstructured":"Fluegen, G. et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat. Cell Biol. 19 (2), 120\u2013132 (2017).","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"49687_CR38","doi-asserted-by":"publisher","first-page":"e32106","DOI":"10.1016\/j.heliyon.2024.e32106","volume":"10","author":"Y Dong","year":"2024","unstructured":"Dong, Y., Bai, J. & Zhou, J. J. Developing a dormancy-associated ECM signature in TNBC that is linked to immunosuppressive tumor microenvironment and selective sensitivity to MAPK inhibitors. Heliyon 10 (11), e32106 (2024).","journal-title":"Heliyon"},{"issue":"12","key":"49687_CR39","doi-asserted-by":"publisher","first-page":"e70556","DOI":"10.1002\/ctm2.70556","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Hypoxia-induced secretory autophagy in cancer-associated fibroblasts promotes ECM remodelling through serglycin secretion in oral squamous cell carcinoma. Clin. Transl Med. 15 (12), e70556 (2025).","journal-title":"Clin. Transl Med."},{"issue":"33","key":"49687_CR40","doi-asserted-by":"publisher","first-page":"e2501642","DOI":"10.1002\/adma.202501642","volume":"37","author":"C Yu","year":"2025","unstructured":"Yu, C. et al. Dual Strategy of Ca(2+) Influx and Collagen Denaturation to Remodel the Extracellular Matrix and Amplify Sonopiezoelectric Therapy. Adv. Mater. 37 (33), e2501642 (2025).","journal-title":"Adv. Mater."},{"issue":"7886","key":"49687_CR41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599 (7886), 673\u2013678 (2021).","journal-title":"Nature"},{"issue":"20","key":"49687_CR42","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1158\/0008-5472.CAN-24-0030","volume":"84","author":"GG Bushnell","year":"2024","unstructured":"Bushnell, G. G. et al. Natural Killer Cell Regulation of Breast Cancer Stem Cells Mediates Metastatic Dormancy. Cancer Res. 84 (20), 3337\u20133353 (2024).","journal-title":"Cancer Res."},{"issue":"3","key":"49687_CR43","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1158\/0008-5472.CAN-05-3092","volume":"66","author":"AC Ranganathan","year":"2006","unstructured":"Ranganathan, A. C. et al. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res. 66 (3), 1702\u20131711 (2006).","journal-title":"Cancer Res."},{"key":"49687_CR44","first-page":"123","volume":"1136","author":"LM Minassian","year":"2019","unstructured":"Minassian, L. M. et al. Hypoxia-Induced Resistance to Chemotherapy in Cancer. Hypoxia Cancer Metastasis. 1136, 123\u2013139 (2019).","journal-title":"Hypoxia Cancer Metastasis"},{"issue":"24","key":"49687_CR45","doi-asserted-by":"publisher","first-page":"e120360","DOI":"10.1172\/jci.insight.120360","volume":"3","author":"DB Johnson","year":"2018","unstructured":"Johnson, D. B. et al. Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3\/FCRL6 engagement. JCI Insight. 3 (24), e120360 (2018).","journal-title":"JCI Insight"},{"issue":"9","key":"49687_CR46","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1158\/2159-8290.CD-15-0563","volume":"5","author":"A Ribas","year":"2015","unstructured":"Ribas, A. Adaptive Immune Resistance: How Cancer Protects from Immune Attack. Cancer Discov. 5 (9), 915\u2013919 (2015).","journal-title":"Cancer Discov."},{"issue":"1","key":"49687_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41523-026-00903-6","volume":"12","author":"A Yilmaz","year":"2026","unstructured":"Yilmaz, A. et al. The CXCL10\/CXCR3 axis is essential for sustaining immunological dormancy in triple-negative breast cancer. NPJ Breast Cancer. 12 (1), 36 (2026).","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"49687_CR48","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.4049\/jimmunol.167.6.3129","volume":"167","author":"J Dunne","year":"2001","unstructured":"Dunne, J. et al. Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15. J. Immunol. 167 (6), 3129\u20133138 (2001).","journal-title":"J. Immunol."},{"issue":"6421","key":"49687_CR49","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1126\/science.aas9090","volume":"362","author":"M Ruscetti","year":"2018","unstructured":"Ruscetti, M. et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science 362 (6421), 1416\u2013 (2018).","journal-title":"Science"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49687-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49687-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49687-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:02:21Z","timestamp":1784250141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49687-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49687"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49687-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were conducted in accordance with relevant guidelines, and the animal study protocol was approved by the Institutional Review Board (or Ethics Committee) of Soochow University (protocol code: 202510A0859). The methods are reported following the ARRIVE guidelines. All animal experiments and procedures strictly adhered to the experimental protocol approved by the Laboratory Animal Ethics Committee of Soochow University, as well as national and international laboratory animal welfare guidelines. All experimental mice were first anesthetized with isoflurane inhalation, and then euthanized by professional researchers proficient in the cervical dislocation method.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22510"}}